Addus HomeCare (NASDAQ:ADUS) Releases Earnings Results

Addus HomeCare (NASDAQ:ADUS) released its quarterly earnings data on Monday. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02, Briefing.com reports. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. Addus HomeCare’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.03 earnings per share.

Addus HomeCare Price Performance

Shares of ADUS stock traded down $7.50 on Tuesday, hitting $121.46. The company’s stock had a trading volume of 71,083 shares, compared to its average volume of 130,842. The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of 28.13, a P/E/G ratio of 2.29 and a beta of 1.04. Addus HomeCare has a fifty-two week low of $81.51 and a fifty-two week high of $136.12. The firm’s fifty day moving average price is $129.93 and its 200-day moving average price is $120.66.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock valued at $3,050,082 over the last three months. 4.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ADUS. TD Cowen boosted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Stephens reaffirmed an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research note on Tuesday, August 6th. Macquarie reissued an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday. Finally, Oppenheimer increased their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $131.38.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.